Nanodrug modified with engineered cell membrane targets CDKs to activate aPD-L1 immunotherapy against liver metastasis of immune-desert colon cancer
- Resource Type
- Article
- Source
- In
Journal of Controlled Release May 2024 369:309-324 - Subject
- Language
- ISSN
- 0168-3659